PortfoliosLab logoPortfoliosLab logo
XHS vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XHS vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Health Care Services ETF (XHS) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


XHS

1D
0.28%
1M
2.77%
YTD
6.32%
6M
5.39%
1Y
16.58%
3Y*
8.47%
5Y*
0.44%
10Y*
7.46%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XHS vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
XHS
SPDR S&P Health Care Services ETF
6.32%18.83%-5.48%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

XHS vs. GERM - Sectors Allocation Comparison


Sectors
XHS
GERM

Healthcare

98.0%
99.3%

Financial Services

2.0%
0.4%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XHS
98.0%
GERM
99.3%

Financial Services

XHS
2.0%
GERM
0.4%

Basic Materials

XHS

-

GERM

-

Communication Services

XHS

-

GERM

-

Consumer Cyclical

XHS

-

GERM

-

Consumer Defensive

XHS

-

GERM

-

Energy

XHS

-

GERM

-

Industrials

XHS

-

GERM

-

Real Estate

XHS

-

GERM

-

Technology

XHS

-

GERM

-

Utilities

XHS

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XHS vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XHS
XHS Risk / Return Rank: 2626
Overall Rank
XHS Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
XHS Sortino Ratio Rank: 2525
Sortino Ratio Rank
XHS Omega Ratio Rank: 2626
Omega Ratio Rank
XHS Calmar Ratio Rank: 2828
Calmar Ratio Rank
XHS Martin Ratio Rank: 2727
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XHS vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XHSGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.18

Calmar ratioReturn relative to maximum drawdown

1.39

Martin ratioReturn relative to average drawdown

3.83

XHS vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


XHSGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

0.57

Drawdowns

XHS vs. GERM - Drawdown Comparison

The maximum XHS drawdown since its inception was -39.32%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for XHS and GERM.


Loading charts...

Drawdown Indicators


XHSGERMDifference

Max Drawdown

Largest peak-to-trough decline

-39.32%

0.00%

-39.32%

Max Drawdown (1Y)

Largest decline over 1 year

-11.99%

0.00%

-11.99%

Max Drawdown (3Y)

Largest decline over 3 years

-17.81%

Max Drawdown (5Y)

Largest decline over 5 years

-32.62%

Max Drawdown (10Y)

Largest decline over 10 years

-39.32%

Current Drawdown

Current decline from peak

-1.78%

0.00%

-1.78%

Average Drawdown

Average peak-to-trough decline

-10.20%

0.00%

-10.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.33%

0.00%

+4.33%

Volatility

XHS vs. GERM - Volatility Comparison

SPDR S&P Health Care Services ETF (XHS) has a higher volatility of 4.80% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that XHS's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XHSGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.80%

0.00%

+4.80%

Volatility (6M)

Calculated over the trailing 6-month period

11.86%

0.00%

+11.86%

Volatility (1Y)

Calculated over the trailing 1-year period

17.56%

0.00%

+17.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.10%

0.00%

+21.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.40%

0.00%

+22.40%

XHS vs. GERM - Expense Ratio Comparison

XHS has a 0.35% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

XHS vs. GERM - Dividend Comparison

XHS's dividend yield for the trailing twelve months is around 0.25%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XHS
SPDR S&P Health Care Services ETF
0.25%0.27%0.38%0.23%0.19%0.20%0.23%2.37%0.34%0.22%0.28%0.93%

Frequently Asked Questions


XHS has higher volatility (4.80%) compared to GERM (0.00%). In terms of maximum drawdown, XHS dropped -39.32% vs GERM's 0.00%.

On 1-year performance, XHS leads with 16.58% vs 0.00% for GERM. On fees, XHS is cheaper at 0.35% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, XHS has performed better with a 16.58% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XHS is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.

XHS has the higher dividend yield at 0.25%, compared with 0.00% for GERM.

XHS tracks S&P Health Care Services Select Industry Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: State Street and Amplify. Their fees differ too: 0.35% for XHS and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for XHS and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer